Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01009333 · ClinicalTrials.gov registry record · NA
InterStim Therapy Programming Study
A NA study of Urinary Urge Incontinence and Urgency Frequency, sponsored by MedtronicNeuro.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
- 1
- Study location
NCT01009333 is a NA study of Urinary Urge Incontinence and Urgency Frequency that has completed, run by MedtronicNeuro. The registered enrollment target is 13 participants, below the 100-participant average among 6 other Urinary Urge Incontinence trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01009333, a NA study of Urinary Urge Incontinence and Urgency Frequency, has completed, sponsored by MedtronicNeuro.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
- 1
- Study location
Study Summary
This study assessed the effect of different InterStim rate settings on voiding diary outcomes. Specifically, the study evaluated how 3 different rate settings affected the number of urinary incontinent episodes per day collected through a voiding diary. The study also evaluated how the 3 different rate settings affected other voiding diary measures including number of voids per day, degree of urgency before each void, number of pads used per day, and number of fecal incontinent episodes, questionnaires, and adverse events.
Conditions Studied
Interventions
- DEVICE InterStim Therapy at rate 5.2 Hz
- DEVICE InterStim Therapy at rate 14 Hz
- DEVICE InterStim Therapy
Study Locations (1)
Michigan
- Kenneth Peters, MD - Royal Oak
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2009-11 |
| Est. Completion | 2010-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01009333
The ClinicalTrials.gov registry entry for NCT01009333 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 100-participant average among 6 other Urinary Urge Incontinence trials with a reported enrollment target (87% lower). The listed sponsor is MedtronicNeuro, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Urinary Urge Incontinence appearing as the primary indexed condition, and to 3 interventions - of which InterStim Therapy at rate 5.2 Hz is the first listed.
NCT01009333 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT01009333 about?
NCT01009333 is a clinical study titled "InterStim Therapy Programming Study". This study assessed the effect of different InterStim rate settings on voiding diary outcomes. Specifically, the study evaluated how 3 different rate settings affected the number of urinary incontinent episodes per day collected through a voiding diary. The study also evaluated how the 3 different r...
What is the current status of trial NCT01009333?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2009-11. Estimated completion is 2010-11.
What conditions does trial NCT01009333 study?
This clinical trial studies the following conditions: Urinary Urge Incontinence, Urgency Frequency.
What interventions are being tested in trial NCT01009333?
The interventions under investigation include: InterStim Therapy at rate 5.2 Hz (DEVICE), InterStim Therapy at rate 14 Hz (DEVICE), InterStim Therapy (DEVICE).
Who is sponsoring clinical trial NCT01009333?
This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01009333 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Urge Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)
RECRUITING · NA
-
Study of 30-Minute Stimulation With the Neuspera Sacral Neuromodulation (SNM) System
RECRUITING · NA
-
RESTORE: An RCT to Evaluate the Efficacy of the Revi System
ACTIVE NOT RECRUITING · NA
-
Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer
RECRUITING · Phase 2
-
Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A
RECRUITING · Phase 4
-
Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial
COMPLETED · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.